2,739
Views
8
CrossRef citations to date
0
Altmetric
Articles

Morphology and histology of silent and symptom-causing atherosclerotic carotid plaques – Rationale and design of the Helsinki Carotid Endarterectomy Study 2 (the HeCES2)

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , , , , ORCID Icon, , ORCID Icon, , ORCID Icon & ORCID Icon show all
Pages 501-510 | Received 22 Feb 2018, Accepted 25 Jun 2018, Published online: 01 Oct 2018

References

  • WHO. The Top 10 Causes of Death. 2014; Available at: http://www.who.int/mediacentre/factsheets/fs310/en/
  • GBD 2016 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017;39010100:1260-1344.
  • Hellings WE, Peeters W, Moll FL, et al. From vulnerable plaque to vulnerable patient: the search for biomarkers of plaque destabilization. Trends Cardiovasc Med. 2007;17:162–171.
  • Mauriello A, Sangiorgi G, Fratoni S, et al. Diffuse and active inflammation occurs in both vulnerable and stable plaques of the entire coronary tree: a histopathologic study of patients dying of acute myocardial infarction. J Am Coll Cardiol. 2005;45:1585–1593.
  • Lombardo A, Biasucci LM, Lanza GA, et al. Inflammation as a possible link between coronary and carotid plaque instability. Circulation. 2004;109:3158–3163.
  • Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381–386.
  • Nuotio K, Soinne L, Hänninen H, et al. Life-threatening coronary disease is prevalent in patients with stenosing carotid artery disease. Int j Stroke. 2015;10:1217–1223.
  • Gupta A, Baradaran H, Schweitzer AD, et al. Carotid plaque MRI and stroke risk: a systematic review and meta-analysis. Stroke. 2013;44:3071–3077.
  • Nuotio K, Lindsberg PJ, Carpén O, et al. Adhesion molecule expression in symptomatic and asymptomatic carotid stenosis. Neurology. 2003;60:1890–1899.
  • Nuotio K, Mäyränpää MI, Saksi J, et al. Endothelial apoptosis does not determine symptom status in carotid artery disease. Cerebrovasc Dis. 2007;23:27–34.
  • Lehtonen-Smeds EM, Mäyränpää M, Lindsberg PJ, et al. Carotid plaque mast cells associate with atherogenic serum lipids, high grade carotid stenosis and symptomatic carotid artery disease. Results from the helsinki carotid endarterectomy study. Cerebrovasc Dis. 2005;19:291–301.
  • Ijäs P, Nuotio K, Saksi J, et al. Microarray analysis reveals overexpression of CD163 and HO-1 in symptomatic carotid plaques. Arterioscler, Thrombo Vasc Biol. 2007;27:154–160.
  • Nuotio K, Isoviita PM, Saksi J, et al. Adipophilin expression is increased in symptomatic carotid atherosclerosis: correlation with red blood cells and cholesterol crystals. Stroke. 2007;38:1791–1798.
  • Isoviita PM, Nuotio K, Saksi J, et al. An imbalance between CD36 and ABCA1 protein expression favors lipid accumulation in stroke-prone ulcerated carotid plaques. Stroke. 2010;41:389–393.
  • Saksi J, Ijäs P, Nuotio K, et al. Gene expression differences between stroke-associated and asymptomatic carotid plaques. J Mol Med. 2011;89:1015–1026.
  • Saksi J, Ijäs P, Mäyränpää MI, et al. Low-Expression Variant of Fatty Acid-Binding Protein 4 Favors Reduced Manifestations of Atherosclerotic Disease and Increased Plaque Stability. Circulation Cardiovasc Gene. 2014;7:588–598.
  • Ijäs P, Saksi J, Soinne L, et al. Haptoglobin 2 allele associates with unstable carotid plaque and major cardiovascular events. Atherosclerosis. 2013;230:228–234.
  • Soinne L, Helenius J, Tatlisumak T, et al. Cerebral hemodynamics in asymptomatic and symptomatic patients with high-grade carotid stenosis undergoing carotid endarterectomy. Stroke. 2003;34:1655–1661.
  • Soinne L, Helenius J, Saimanen E, et al. Brain diffusion changes in carotid occlusive disease treated with endarterectomy. Neurology. 2003;61:1061–1065.
  • Soinne L, Saimanen E, Malmberg-Céder K, et al. Association of the fibrinolytic system and hemorheology with symptoms in patients with carotid occlusive disease. Cerebrovasc Dis. 2005;20:172–179.
  • Soinne L, Helenius J, Tikkala I, et al. The effect of severe carotid occlusive disease and its surgical treatment on cognitive functions of the brain. Brain Cogn. 2009;69:353–359.
  • European Stroke Organisation (ESO) Executive Committee. ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008;25:457–507.
  • Adams HPJ, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. Stroke. 1993;24:35–41.
  • Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet. 2007;369:283–292.
  • North American Symptomatic Carotid Endarterectomy Trial. Methods, patient characteristics, and progress. Stroke. 1991;22:711–720.
  • Saba L, Caddeo G, Sanfilippo R, et al. Efficacy and sensitivity of axial scans and different reconstruction methods in the study of the ulcerated carotid plaque using multidetector-row CT angiography: comparison with surgical results. AJNR Am J Neuroradiol. 2007;28:1061–1723.
  • Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation. 2003;108:1664–1672.
  • Verhoeven BA, Velema E, Schoneveld AH, et al. Athero-express: differential atherosclerotic plaque expression of mRNA and protein in relation to cardiovascular events and patient characteristics. Rationale and design. Eur J Epidemiol. 2004;19:1127–1133.
  • Redgrave JN, Lovett JK, Gallagher PJ, et al. Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study. Circulation. 2006;113:2320–2328.
  • Virmani R, Burke AP, Farb A, et al. Pathology of the vulnerable plaque. J Am Coll Cardiol. 2006;478: Suppl:13–18.
  • Finn AV, Nakano M, Narula J, et al. Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol. 2010;30:1282–1292.
  • Stone GW, Maehara A, Lansky AJ, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364:226–235.
  • Arbab-Zadeh A, Fuster V. The myth of the "vulnerable plaque": transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment. J Am Coll Cardiol. 2015;65:846–855.
  • Libby P, Pasterkamp G. Requiem for the 'vulnerable plaque'. Eur Heart J. 2015;36:2984–2987.
  • Pasterkamp G, den Ruijter HM, Libby P. Temporal shifts in clinical presentation and underlying mechanisms of atherosclerotic disease. Nat Rev Cardiol. 2017;14:21–29.
  • van Lammeren GW, den Ruijter HM, Vrijenhoek JEP, et al. Time-dependent changes in atherosclerotic plaque composition in patients undergoing carotid surgery. Circulation. 2014;129:2269–2276.
  • Artom N, Montecucco F, Dallegri F, et al. Carotid atherosclerotic plaque stenosis: the stabilizing role of statins. Eur J Clin Invest. 2014;44:1122–1134.